Company news

Hunan Nucien Pharmaceutical Co. Ltd. news in 2025

Hunan Nucien Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

December 26, 2025

Notice on Convening the 2nd Extraordinary General Meeting in 2025

December 10, 2025

Report for Q3 2025

October 30, 2025

Announcement on Early Returning of Raised Funds Temporarily Used for Supplementing Current Capital

October 21, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

October 10, 2025

Announcement on Serious Abnormal Fluctuations in Stock Trading

October 9, 2025

Announcement on Receiving Notice of Litigation Filing from China Securities Regulatory Commission

September 30, 2025

Announcement on Progress in Planning Major Asset Restructuring

September 26, 2025

Announcement on Shareholding Reduction Plan for Shareholders

September 24, 2025

Announcement on Resolutions of the 16th Meeting of the 2nd Board of Supervisors

September 22, 2025

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing

September 12, 2025

Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase

August 29, 2025

Special Report on Semi-annual Deposit and Use of Raised Funds in 2025

August 28, 2025

Indicative Announcement on Planning Major Asset Restructuring and Signing the "Agreement of Intention for Acquisition"

August 26, 2025

Announcement on Abnormal Fluctuations in Stock Trading

July 30, 2025

Announcement on Resolution of the 2024 Annual General Meeting

June 13, 2025

Announcement on Initially Repurchasing the Company's Shares through Call Auction

May 30, 2025

Announcement on Using Extra Raised Funds to Permanently Supplement Current Capital

May 23, 2025

Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders without Sales Limit Concerning Shares Repurchase

May 7, 2025

Announcement on Proposed Cancellation of Subsidiary

April 29, 2025